
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
A few of the cardiac electronic devices that can be implanted inside the heart and used to monitor or control irregular heartbeats in people with specific heart rhythm disorders and heart failure include implantable cardiac pacemakers, implantable cardioverter defibrillators (ICDs), biventricular pacemakers, and cardiac loop recorders.
Vascular medical devices are any devices that are put into the arteries, veins, or the heart itself in order to treat, prevent, or manage a disease, injury, or other condition.
The cardiovascular, peripheral, and neurovascular systems' anatomy is part of this vascular system.
The Japan Cardiovascular Medical Devices market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
First inserted cardiac monitor introduced by Medtronic in Japan The Reveal DX Insertable Cardiac Monitor (ICM), which the Japanese government identified as a high-priority medical device and which is the first insertable cardiac monitor to be introduced in Japan, was approved by Japanese regulatory authorities today.
The Reveal DX ICM sheds light on mysterious fainting episodes, often referred to as syncope. Syncope is challenging to identify since episodes are frequently too rare and unpredictable to be picked up by common monitoring methods like ECG Holter monitors or external loop recorders.
Due to the limitations placed on the patient's everyday activities and the low possibility that an incident would occur during the monitoring period, these tests are only valid for 24 hours and one month, respectively. As a result, the testing may.
The Reveal DX ICM, which is about the size of a memory stick and is inserted just under the skin of the chest area, can monitor patients for up to three years, enabling long-term, continuous cardiac monitoring.
According to the manufacturer, patients can instruct the gadget to record any events at any time while it automatically detects, stores, and records arrhythmias.
If the patient has a syncopal episode, the data gathered by the device might be able to tell the doctor whether the episode is caused by an arrhythmia.
The Reveal DX was given "high priority" status by the Ministry of Health, Labor, and Welfare for approval in Japan because there hasn't been a comparable device accessible in that country.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |